Drug Master Files for: EVEROLIMUS
✉ Email this page to a colleague
EVEROLIMUS Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
26350 | A | II | 6/14/2013 | CONCORD BIOTECH LTD | EVEROLIMUS |
26738 | A | II | 12/17/2012 | HANGZHOU HUADONG MEDICINE GROUP KANGRUN PHARMACEUTICAL CO LTD | EVEROLIMUS |
26819 | A | II | 2/8/2013 | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | EVEROLIMUS PRE-MIX |
27216 | A | II | 7/1/2013 | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | EVEROLIMUS |
29405 | A | II | 6/5/2015 | CHENGDU YACHT BIO-TECHNOLOGY CO LTD | EVEROLIMUS |
29651 | A | II | 9/30/2015 | BIOCON LTD | EVEROLIMUS (WITH 0.2% BHT) |
29657 | A | II | 9/30/2015 | BIOCON LTD | EVEROLIMUS |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information